SCHEMBL23725966

SCHEMBL23725966

ClCc1ncc2cc(Br)ccc2n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.42
NPM1 P06748 1/20 0.36
ALK Q9UM73 1/20 0.36
ACACB O00763 1/20 0.36
HTT P42858 4/20 0.34
CYP1A2 P05177 2/20 0.34
CYP2C19 P33261 2/20 0.34
NOS1 P29475 1/20 0.34
METAP2 P50579 1/20 0.34
CSNK2A1 P68400 1/20 0.34
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
PABPC1 P11940 1/20 0.33
TLR2 O60603 1/20 0.33
ALDH1A1 P00352 2/20 0.33
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
HPGD P15428 1/20 0.33
MTOR P42345 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31519291 0.86 BACE1 (0.43) BACE1NPM1ALKHTTCYP1A2
SCHEMBL14592822 0.82 BACE1 (0.42) BACE1ACACBHTTCYP1A2CYP2C19
SCHEMBL10271490 0.82 BACE1 (0.42) BACE1ACACBHTTCYP1A2CYP2C19
SCHEMBL22798723 0.77 NPC1 (0.42) BACE1ACACBHTTCYP1A2CYP2C19
SCHEMBL1570789 0.76 HTT (0.49) BACE1NPM1ALKHTTCYP1A2
SCHEMBL1461279 0.75 BACE1 (0.48) BACE1NPM1ALKHTTCYP1A2
SCHEMBL30839232 0.75 BACE1 (0.48) BACE1NPM1ALKHTTCYP1A2
SCHEMBL874900 0.73 KMT2A (0.44) BACE1CYP1A2ALDH1A1KDM4EHPGD
SCHEMBL29756554 0.73 KMT2A (0.44) BACE1CYP1A2ALDH1A1KDM4EHPGD
Hydrochloric Acid SCHEMBL10828863 0.72 KMT2A (0.43) BACE1CYP1A2ALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (US) 2023-05-11 US disclosed
EP-4100381-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2022-12-14 EP disclosed
CN-115413275-A Substituted 1,1 , -biphenyl compounds and methods of use thereof 爱彼特生物制药公司 2022-11-29 CN disclosed
WO-2021158481-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA, INC. (US) 2021-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME HAVCR2, HMBS, VHL BACE1 401/4885NPM1 1343/4885ALK 2448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.